Hara, Natsuko
Suwanai, Hirotsugu http://orcid.org/0000-0001-9102-630X
Yakou, Fumiyoshi
Ishii, Keitaro
Iwasaki, Hajime
Abe, Hironori
Shikuma, Jumpei
Sakai, Hiroyuki
Miwa, Takashi
Suzuki, Ryo
Funding for this research was provided by:
Japan Society for the Promotion of Science
Article History
Received: 16 March 2023
Accepted: 1 May 2023
First Online: 13 May 2023
Compliance with ethical standards
:
: Financial interests: H.Suwanai receives personal fees from Nippon Boehringer Ingelheim Co., Ltd. R.S. receives personal fees from Ono Pharmaceutical CO., Ltd, and MSD K.K. N.H., F.Y., K.I., H.I., H.A., H.Sakai., J.S. and T.M. have no financial interests to disclose. All authors have no relevant no non-financial interests to disclose.
: The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the institutional review board of Tokyo Medical University (Approval No. T2021-0005). The design of this prospective study is in accordance with STROBE guidelines.
: Written informed consents were obtained from all individual patients included in the study.